[Definitive radiotherapy versus radiochemotherapy with weekly docetaxel in patients with head and neck cancer and cisplatin intolerance].
作者信息
Schmalz Claudia, Dunst Jürgen
机构信息
Klinik für Strahlentherapie/Radioonkologie, UKSH, Campus Kiel, Kiel, Deutschland.
出版信息
Strahlenther Onkol. 2023 Sep;199(9):869-870. doi: 10.1007/s00066-023-02113-6. Epub 2023 Jun 26.
Abstract
摘要
相似文献
1
[Definitive radiotherapy versus radiochemotherapy with weekly docetaxel in patients with head and neck cancer and cisplatin intolerance].[在顺铂不耐受的头颈癌患者中，根治性放疗与每周一次多西他赛同步放化疗的对比研究]
Strahlenther Onkol. 2023 Sep;199(9):869-870. doi: 10.1007/s00066-023-02113-6. Epub 2023 Jun 26.
2
Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II study.多西他赛/顺铂/5-氟尿嘧啶诱导化疗后随机分为两种基于顺铂的同步放化疗方案治疗局部晚期头颈癌患者（CONDOR研究）（荷兰头颈学会08-01）：一项随机II期研究
Eur J Cancer. 2016 Jan;52:77-84. doi: 10.1016/j.ejca.2015.09.024. Epub 2015 Dec 1.
3
Concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck.同步放化疗联合多西紫杉醇、顺铂和氟尿嘧啶（TPF）治疗局部晚期头颈部鳞状细胞癌。
Jpn J Clin Oncol. 2014 May;44(5):416-21. doi: 10.1093/jjco/hyu026. Epub 2014 Mar 30.
4
Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234.头颈部高危鳞状细胞癌的术后放化疗及西妥昔单抗治疗：放射肿瘤学组RTOG-0234
J Clin Oncol. 2014 Aug 10;32(23):2486-95. doi: 10.1200/JCO.2013.53.9163. Epub 2014 Jul 7.
5
Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with concurrent weekly cisplatin chemoradiotherapy for locally advanced head and neck squamous cell carcinoma.多西他赛、顺铂和5-氟尿嘧啶诱导化疗联合顺铂每周同步放化疗用于局部晚期头颈部鳞状细胞癌的可行性和疗效
Int J Clin Oncol. 2015 Jun;20(3):431-7. doi: 10.1007/s10147-014-0726-y. Epub 2014 Jul 5.
6
The efficacy of induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil combined with cisplatin concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: a matched pair analysis.多西他赛、顺铂和 5-氟尿嘧啶诱导化疗联合顺铂同期放化疗治疗局部晚期头颈部鳞状细胞癌的疗效：配对分析。
Clin Oncol (R Coll Radiol). 2013 Nov;25(11):647-53. doi: 10.1016/j.clon.2013.07.007. Epub 2013 Aug 13.
7
Long term toxicity and tolerance of concurrent docetaxel with radiotherapy in cisplatin-ineligible head and neck cancer patients.多西他赛与放疗同步应用于不符合顺铂治疗条件的头颈癌患者的长期毒性和耐受性
Oral Oncol. 2022 Jul;130:105908. doi: 10.1016/j.oraloncology.2022.105908. Epub 2022 May 27.
8
9
Phase 2 study of docetaxel, cisplatin, and concurrent radiation for technically resectable stage III-IV squamous cell carcinoma of the head and neck.多西他赛、顺铂及同步放疗用于技术上可切除的Ⅲ-Ⅳ期头颈部鳞状细胞癌的Ⅱ期研究
Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):934-41. doi: 10.1016/j.ijrobp.2014.12.032.
10
Concurrent chemoradiation with weekly cisplatin, docetaxel and gefitinib: A study to assess feasibility, toxicity and immediate response.顺铂、多西他赛和吉非替尼每周一次同步放化疗：一项评估可行性、毒性和近期疗效的研究。
J Cancer Res Ther. 2013 Jul-Sep;9(3):392-6. doi: 10.4103/0973-1482.119313.
引用本文的文献
1
Gender parity in radiation oncology in Germany: a 2024 analysis of professional roles and academic training.德国放射肿瘤学领域的性别平等：2024年专业角色与学术培训分析
Strahlenther Onkol. 2025 Apr 8. doi: 10.1007/s00066-025-02398-9.
本文引用的文献
1
Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation.头颈部癌症患者中多西他赛作为放射增敏剂的 III 期随机试验结果，不适合顺铂为基础的放化疗。
J Clin Oncol. 2023 May 1;41(13):2350-2361. doi: 10.1200/JCO.22.00980. Epub 2023 Jan 27.
2
Cisplatin Eligibility Issues and Alternative Regimens in Locoregionally Advanced Head and Neck Cancer: Recommendations for Clinical Practice.局部晚期头颈癌的顺铂适用问题及替代方案：临床实践建议
Front Oncol. 2019 Jun 11;9:464. doi: 10.3389/fonc.2019.00464. eCollection 2019.
3
Clinical recommendations for defining platinum unsuitable head and neck cancer patient populations on chemoradiotherapy: A literature review.关于在放化疗中定义铂类不适用头颈癌患者群体的临床建议：一项文献综述
Oral Oncol. 2016 Feb;53:10-6. doi: 10.1016/j.oraloncology.2015.11.019. Epub 2015 Dec 19.
4
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.头颈部癌化疗的荟萃分析（MACH-NC）：93项随机试验及17346例患者的最新情况
Radiother Oncol. 2009 Jul;92(1):4-14. doi: 10.1016/j.radonc.2009.04.014. Epub 2009 May 14.
5
Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial.同步氟尿嘧啶-丝裂霉素的超分割加速放化疗在局部晚期头颈癌中比单纯剂量递增的超分割加速放射治疗更有效：德国癌症协会放射治疗合作临床试验组95-06前瞻性随机试验的最终结果。
J Clin Oncol. 2005 Feb 20;23(6):1125-35. doi: 10.1200/JCO.2005.07.010.
Zotero 插件